Cited by 120Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

In vivo monoamine oxidase inhibition by d-amphetamine

Miller, Harold H., Shore, Parkhurst A., Clarke, David E.·1980·Biochemical Pharmacology

DOI 10.1016/0006-2952(80)90429-3

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0006-2952(80)90429-3

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,597
Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices
Heikkila, R. E., Orlansky, H., & Cohen, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90152-5 · Cited by 468
Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid
Roth, R. H., Murrin, L. C., & Walters, J. R. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90268-5 · Cited by 364
Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs
Neff, N. H., & Yang, H. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90089-7 · Cited by 333
A COMPARISON OF THE CAPACITIES OF ISOMERS OF AMPHETAMINE, DEOXYPIPRADROL AND METHYLPHENIDATE TO INHIBIT THE UPTAKE OF TRITIATED CATECHOLAMINES INTO RAT CEREBRAL CORTEX SLICES, SYNAPTOSOMAL PREPARATIONS OF RAT CEREBRAL CORTEX, HYPOTHALAMUS AND STRIATUM AND INTO ADRENERGIC NERVES OF RABBIT AORTA
Ferris, R. M., Tang, F. L. M., & Maxwell, R. A. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 302
Monoamine Oxidase and its Inhibition.
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-1-123_1 · Cited by 263
Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs
Westerink, B. H. C., & Korf, J. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90331-9 · Cited by 240
Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase
Donnelly, C. H., & Murphy, D. L. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90398-7 · Cited by 238
Millennium Cohort Study: Age 17, Sweep 7, 2018
University of London, I. O. E. (2021) · VocBench (University of Rome Tor Vergata) · doi:10.5255/ukda-sn-8682-2 · Cited by 206
The effect of tropolone on the formation of 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the brain of the mouse
Murphy, G. F., Robinson, D. S., & Sharman, D. F. (1969) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1969.tb08308.x · Cited by 198

Show all 32 references

Research works printed but not linked: 11

Ziance, 1972, J. Pharmac. exp. Ther., 182, 284
Houslay, 1976, Life Sci., 19, 467, 10.1016/0024-3205(76)90224-1 · DOI
Callingham, 1977, Br. J. Pharmac., 61, 470P
Miller, 1978, Commun. Psychopharmac., 2, 319
Dial, 1977, Res. Commun. Chem. Path. Pharmac., 17, 145
Roffler-Tarlov, 1971, Kr. J. Pharmac., 42, 343
Demarest, 1978, Pharmacologist, 20, 217
Iverson, 1965, J. Pharmac. exp. Ther., 150, 173
Elchisak, 1976, Psychopharmac. Commun., 2, 411
Ferris, 1972, J. Pharmac. exp. Ther., 181, 407
Miller, 1977, Pharmacologist, 19, 239

Sorted by citations

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…receptor agonist to induce calcium increases and NE release in bovine adrenal chromaffin cells May et al. (1988) • AMP stimulated DA release in the caudate nucleus of rats, as measured by in vivo fast-scan cyclic voltammetry Miller et al. (1980) • AMP inhibited MAO type A activity Mukherjee…”
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626
“This is consistent with AMPH entering nerve terminals and inhibiting monoamine oxidase (MAO), one of the known actions of AMPH (Green and El Haut, 1978; Miller et al., 1980).”
Background
Amphetamine, past and present – a pharmacological and clinical perspective
Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482532 · Cited by 653
“Amphetamine’s isomers have long been known to be inhibitors of this important catabolising enzyme (Mantle et al., 1976; Miller et al., 1980; Robinson, 1985).”
Background
In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐Amphetamine
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
Gerlach, M., & Riederer, P. F. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 496
“Since amphetamines on the one hand liberate dopamine in large amounts in a nonphysiological fashion, and on the other hand also inhibit its enzymatic breakdown by inhibition of MAO (Miller et al., 1980), "oxidative stress" such as that which occurs following 6-OHDA - may be considered a possible causative factor in th…”
Background
Mapping Human Brain Monoamine Oxidase A and B with11C-Labeled Suicide Inactivators and PET
Fowler, J. S., MacGregor, R. R., Wolf, A. P., Arnett, C. D., Dewey, S. L., Schlyer, D. J., Christman, D. R., Logan, J., Smith, M. R., Sachs, H., et al. (1987) · Science · doi:10.1126/science.3099392 · Cited by 389
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
Kuczenski, R., Segal, D., Cho, A., & Melega, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01308.1995 · Cited by 376
“It is unlikely that the decline in metabolites reflects AMPH inhibition of monoamine oxidase, since most evidence suggests that such an effect occurs only at relatively high AMPH concentrations (Green and El Hait, 1980; Miller et al., 1980).”
Background
In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
Schmidt, C. J., Levin, J. A., & Lovenberg, W. M. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90729-5 · Cited by 297
Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study
Butcher, S. P., Fairbrother, I. S., Kelly, J. S., & Arbuthnott, G. W. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02919.x · Cited by 289
Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic Mice
Cadet, J. L., Sheng, P., All, S., Rothman, R. B., Carlson, E. J., & Epstein, C. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010380.x · Cited by 263
A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse
Dwoskin, L. P., & Crooks, P. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00899-1 · Cited by 220
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
Heal, D. J., Cheetham, S. C., & Smith, S. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.020 · Cited by 198
“Surprisingly, it is not known whether D- or DL-MPH are inhibitors of MAO.”
The functional role of monoamine oxidases A and B in the mammalian central nervous system
Berry, M. D., Juorio, A. V., & Paterson, I. A. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90081-7 · Cited by 181
Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats
Gratton, A. P., & Wise, R. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04130.1994 · Cited by 171
“Increases in voltammetric signals have been recorded in both the feeding (Mitchell and Gratton, 1992) and copulation paradigms (Phillips et al., I99 1). Kalivas and Duffy (1990) found microdialysis evidence of increased NAcc DA when rats with a history of cocaine injections were given saline injections and placed in t…”
Background
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
“The ability of AMPH to block MAO has been repeatedly demonstrated both in vitro and in vivo (Mantle et al., 1976; Green and el Hait, 1978; Clarke et al., 1979; Miller et al., 1980; Robinson, 1985).”
Background
Intracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells
Mosharov, E. V., Gong, L., Khanna, B., Sulzer, D., & Lindau, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05835.2003 · Cited by 142
“The actions of amphetamines include inhibition of mitochondrial monoamine oxidase ( MAO ) ( Davidson et al .”
Influential
Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine
Stefański, R., Ladenheim, B., Lee, S. H., Cadet, J. L., & Goldberg, S. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00094-1 · Cited by 139
Lobeline and Nicotine Evoke [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine: Differential Inhibition of Synaptosomal and Vesicular [3H]Dopamine Uptake
Teng, L., Crooks, P. A., Sonsalla, P. K., & Dwoskin, L. P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36537-1 · Cited by 133
Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study
Zetterström, T., Sharp, T., & Ungerstedt, U. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90002-6 · Cited by 130
Kinetics, mechanism, and inhibition of monoamine oxidase
Ramsay, R. R., & Albreht, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1861-9 · Cited by 108
“1976; Dorris 1982) or other drugs (McCoubrey 1957; Yang and Neff 1974) before moving to in vivo pharmacology (Youdim et al. 1971; Miller et al. 1980; Riederer and Jellinger 1983; Da Prada et al. 1990).”
Background
A review of the pharmacology of selegiline
Heinonen, E. H., & Lammintausta, R. A. S. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05020.x · Cited by 103
Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish
Kyzar, E. J., Stewart, A., Landsman, S., Collins, C. J., Gebhardt, M. J., Robinson, K. S. L., & Kalueff, A. V. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.033 · Cited by 91
The reverse transport of DA, what physiological significance?
Leviel, V. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00076-0 · Cited by 87
Lobeline Inhibits the Neurochemical and Behavioral Effects of Amphetamine
Miller, D. K., Crooks, P. A., Teng, L., Witkin, J. M., Munzar, P., Goldberg, S. R., Acri, J. B., & Dwoskin, L. P. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38847-0 · Cited by 86
Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission
Leng, A., Feldon, J., & Ferger, B. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.011 · Cited by 83
The neurotoxicity of amphetamines during the adolescent period
Gomes, A., Costa, V. M., Feio‐Azevedo, R., Bastos, M. D. L., Carvalho, F. D., & Capela, J. P. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.12.001 · Cited by 82
Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with pet in nonhuman primates
Ginovart, N., Farde, L., Halldin, C., & Swahn, C.-G. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199902)31:2 · Cited by 76
A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase
Clarke, D. E., Lyles, G. A., & Callingham, B. A. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90231-3 · Cited by 77
Self-citation
Neuropharmacology of drugs affecting food intake
Sugrue, M. F. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90057-x · Cited by 72
Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine
Fuller, R. W., & Hemrick-Luecke, S. K. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90027-2 · Cited by 69
Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice
Patel, J. C., Mooslehner, K. A., Chan, P. M., Emson, P. C., & Stamford, J. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01732.x · Cited by 65
Monoamine oxidase inhibitor antidepressants
Youdim, M. B. H., & Finberg, J. P. M. (1985) · Elsevier eBooks · doi:10.1016/b978-0-444-90350-1.50008-8 · Cited by 63
3-methoxytyramine: Its suitability as an indicator of synaptic dopamine release
Waldmeier, P. C., Lauber, J., Blum, W., & Richter, W. J. (1981) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499838 · Cited by 62
“There is now convincing evidence that damphetamine preferentially inhibits intraneuronal MAO A in dopaminergic and probably also in other monoaminergic neurons (Braestrup 1977; Green and E1 Hait 1978; Parkinson and Callingham 1979; Miller et al 1980; for a discussion of the evidence see Clarke 1980), in addition to it…”
Background
Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation
Cadet, J. L., & Krasnova, I. N. (2007) · Neurotoxicity Research · doi:10.1007/bf03033915 · Cited by 59
Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice
Wilson, G. A., & Furman, B. L. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90027-9 · Cited by 53
Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: In vivo voltammetry studies
de Séréville, J.-E., Boer, C., Rambert, F. A., & Duteil, J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90115-5 · Cited by 49
Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine
Hagino, Y., Kasai, S., Han, W., Yamamoto, H., Nabeshima, T., Mishina, M., & Ikeda, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013722 · Cited by 48
“inhibition of monoamine oxidase (MAO) activity [22–24].”
Influence of a carrier transport process on in vivo release and metabolism of dopamine: Dependence of extracellular Na+
Hurd, Y. L., & Ungerstedt, U. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90137-9 · Cited by 46
The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: Evidence for differences in the effects of methamphetamine and amphetamine
Peat, M. A., Warren, P. F., Bakhit, C., & Gibb, J. W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90179-7 · Cited by 43
Nitrous Oxide and Xenon Prevent Amphetamine-Induced Carrier-Mediated Dopamine Release in a Memantine-Like Fashion and Protect Against Behavioral Sensitization
David, H., Ansseau, M., Lemaire, M., & Abraini, J. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.007 · Cited by 40
Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: Time course and time-dependent interactions with amfonelic acid
Steranka, L. R. (1982) · Brain Research · doi:10.1016/0006-8993(82)90477-2 · Cited by 39
Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides
Silvia, C. P., Jaber, M., King, G. R., Ellinwood, E. H., & Caron, M. G. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00399-5 · Cited by 37
Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum
Kitanaka, N., Kitanaka, J., & Takemura, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.026 · Cited by 36
Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis
Matos, F. F., Rollema, H., & Basbaum, A. I. (1990) · Brain Research · doi:10.1016/0006-8993(90)90192-e · Cited by 36
Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue
Johnson, M. P., Xuemei, H., & Nichols, D. E. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90106-c · Cited by 35
Activation of Protein Kinase C (PKC) by 3,4-Methylenedioxymethamphetamine (MDMA) Occurs Through the Stimulation of Serotonin Receptors and Transporter
Kramer, H. K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00026-2 · Cited by 35
“Cocaine is a highly selective DA and NE uptake inhibitor but is a relatively weak 5-HT releaser in a synaptosomal preparations (EC50 10.0 mmol/L) (Miller et al. 1980; Hyde and Bennett 1994; Kramer and Azmitia 1994).”
BackgroundInfluential
CNS-targeting pharmacological interventions for the metabolic syndrome
Stemmer, K., Müller, T. D., DiMarchi, R. D., Pfluger, P. T., & Tschöp, M. H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129195 · Cited by 33
In vivo analysis of the role of dopamine in stimulant and opiate self-administration.
Gratton, A. P. (1996) · PubMed · Cited by 34
Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine
Miller, H. H., & Shore, P. A. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90369-7 · Cited by 32
Self-citation
Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders
Hutson, P. H., Tarazi, F. I., Madhoo, M., Slawecki, C., & Patkar, A. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.005 · Cited by 31
“, 1987; Ritz & Kuhar, 1989) and weak inhibition of MAO-A (Miller et al., 1980; Karoum et al., 1994).”
Background
Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase
Andree, T. H., & Clarke, D. E. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90469-5 · Cited by 30
Self-citation
Differential action of (+)‐amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens
Wieczorek, W. J., & Kruk, Z. L. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14813.x · Cited by 28
Amphetamine augments action potential‐dependent dopaminergic signaling in the striatumin vivo
Ramsson, E. S., Covey, D. P., Daberkow, D. P., Litherland, M. T., Juliano, S. A., & Garris, P. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07258.x · Cited by 26
“Early studies demonstrated DA synthesis activation (Kuczenski 1975), monoamine oxidase inhibition (Miller et al. 1980), competitive blockade of DA uptake (Krueger 1990), depletion of vesicular DA stores (Floor and Meng 1996), and”
Background
Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolites
Cheng, C., & Wooten, G. F. (1982) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(82)90066-3 · Cited by 25
The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism
Ellison, G. D., & Ratan, R. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90703-2 · Cited by 24
Effect of enantiomers of deprenyl (selegiline) and amphetamine on physical abuse liability and cortical electrical activity in rats
Nickel, B., Schulze, G., & Szelenyi, I. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90103-x · Cited by 23
Effects of Zoxazolamine and Related Centrally Acting Muscle Relaxants on Nigrostriatal Dopaminergic Neurons
Matthews, R. T., McMillen, B. A., Speciale, S. G., Jarrah, H. S., Shore, P. A., Sanghera, M. K., Shepard, D. S., & German, D. C. (1984) · Brain Research Bulletin · doi:10.1016/0361-9230(84)90163-1 · Cited by 23
Self-citation
The effect of amperozide on uptake and release of [3H]‐dopamine in vitro from perfused rat striatal and limbic brain areas
Eriksson, E., & Christensson, E. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb01606.x · Cited by 23
Inhibition of Brain Type A Monoamine Oxidase and 5‐Hydroxytryptamine Uptake by Two Amphetamine Metabolites, p‐Hydroxyamphetamine and p‐Hydroxynorephedrine
Arai, Y., Kim, S. K., Kinemuchi, H., Tadano, T., Satoh, S., Satoh, N., & Kisara, K. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04151.x · Cited by 22
Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP
Melamed, E., Rosenthal, J., COHEN, O., Uzzan, A., & Globus, M. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90047-4 · Cited by 22
Tyramine‐induced noradrenaline release from rat brain slices: prevention by (‐)‐deprenyl
Glover, V. A. S., PYCOCK, C. J., & Sandler, M. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11059.x · Cited by 21
Endogenous Dopamine (Da) Modulates [3H]spiperone Binding in Vivo in Rat Brain
Bischoff, S. F., Krauss, J., Grunenwald, C., Gunst, F., Heinrich, M., Schaub, M., Stöcklin, K., Vassout, A., Waldmeier, P. C., & Maître, L. (1991) · Journal of Receptor Research · doi:10.3109/10799899109066397 · Cited by 21
A simple method for screening Monoamine Oxidase (MAO) inhibitory drugs for type preference
Dorris, R. L. (1982) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(82)90025-0 · Cited by 20
Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats
Marek, G. J., Vosmer, G. L., & Seiden, L. S. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90147-a · Cited by 20
Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within μ-opioid receptor knockout mice: a microdialysis study
Lan, K., Ma, T., Lin‐Shiau, S., Liu, S., & Ho, I.-K. (2007) · Journal of Biomedical Science · doi:10.1007/s11373-007-9218-7 · Cited by 18
“to DOPAC and/or inhibition of intra-neuronal MAO activity [37].”
Background
Effects of d-Methamphetamine on Monkey Brain Monoamine Oxidase, In Vivo and In Vitro
Egashira, T., Yamamoto, T., & Yamanaka, Y. (1987) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)43433-1 · Cited by 18
Methamphetamine Reward in Mice as Assessed by Conditioned Place Preference Test with Supermex® Sensors: Effect of Subchronic Clorgyline Pretreatment
Kitanaka, N., Kitanaka, J., Tatsuta, T., Watabe, K., Morita, Y., & Takemura, M. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9081-3 · Cited by 18
Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice
Sershen, H. W., Mason, M. F., Reith, M. E. A., Hashim, A. T., & Lajtha, Á. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90140-1 · Cited by 17
Animal Models of Amphetamine Psychosis: Neurotransmitter Release from Rat Brain Slices
Lillrank, S. M., Oja, S. S., Saransaari, P., & Seppälä, T. T. (1991) · International Journal of Neuroscience · doi:10.3109/00207459109082032 · Cited by 17
Voltammetric Detection of Dopamine Release in the Rat Corpus Striatuma
Wightman, R. M., Kuhr, W. G., & Ewing, A. G. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb23607.x · Cited by 16
Midbrain Dopamine Neurons Defined by TrpV1 Modulate Psychomotor Behavior
Serra, G. P., Guillaumin, A., Dumas, S., Vlcek, B., & Wallén‐Mackenzie, Å. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.726893 · Cited by 15
“…locomotion is primarily based on cKO studies of the GLU aspect of the DA-GLU phenotype, either via cKO of the Vglut2 gene (Birgner et al., 2010; Hnasko et al., 2010; Fortin et al., 2012) or the glutamate recycling enzyme glutaminase (gene Gls1) (Mingote et al., 2017) in DA neurons.”
Background
Inhibition of monoamine oxidase (MAO) by α-ethylphenethylamine and N,α-diethylphenethylamine, two compounds related to dietary supplements
Santillo, M. F. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.10.009 · Cited by 15
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Drug Target Insights · doi:10.1177/117739280600100001 · Cited by 15
“1993), while the inhibition is weak compared with the actions of synthetic MAO inhibitors (Mantle et al. 1976; Miller et al. 1980).”
Background
3,4‐Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy
Lebsanft, H. B., Kohles, T., Kovar, K., & Schmidt, W. (2004) · Synapse · doi:10.1002/syn.20102 · Cited by 15
Stereospecific long-term effects of amphetamine on striatal dopamine neurons in rats
Steranka, L. R. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90119-9 · Cited by 15
Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine
Steuer, A. E., Boxler, M. I., Stock, L., & Kræmer, T. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.12.001 · Cited by 14
Neurochemical effects of an acute treatment with 4-methylaminorex: a new stimulant of abuse
Bunker, C. F., Johnson, M., Gibb, J. W., Bush, L. G., & Hanson, G. R. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90597-y · Cited by 14
Suppressive effects of trihexyphenidyl on methamphetamine‐induced dopamine release as measured by in vivo microdialysis
Shimosato, K., Nagao, N., Watanabe, S., & Kitayama, S. (2003) · Synapse · doi:10.1002/syn.10191 · Cited by 14
“However, based on the fact that amphetamine inhibits MAO only at high doses (2–20 mg/ kg) (Miller et al., 1980), it is unlikely that the MAO inhibition accounts for the decrease in DOPAC level following the low dose (1 mg/kg) of MAP in the present study.”
Background
Involvement of intraterminal dopamine compartments in the amine release in the cat striatum
Leviel, V., & Guibert, B. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90715-4 · Cited by 14
Amphetamine and the Smart Drug 3,4-Methylenedioxypyrovalerone (MDPV) Induce Generalization of Fear Memory in Rats
Colucci, P., Mancini, G. F., Santori, A., Zwergel, C., Mai, A., Trezza, V., Roozendaal, B., & Campolongo, P. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00292 · Cited by 13
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Europe PMC (PubMed Central) · Cited by 13
[3H]dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats
Masuoka, D. T., Alcaraz, A. F., & Schott, H. F. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90406-3 · Cited by 13
Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats
Kitanaka, N., Kitanaka, J., Watabe, K., & Takemura, M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.058 · Cited by 12
Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats
Moser, A., Siebecker, F., Nobbe, F. A., & B�hme, V. (1996) · Experimental Brain Research · doi:10.1007/bf00227181 · Cited by 12
“S(+)-amphetamine is reported to have at least five distinct mechanisms of action (Iravani and Kruk 1995): release of dopamine through carrier-mediated diffusion via reversal of the dopamine uptake system (Connor and Kuczenski 1986), inhibition of dopamine reuptake (Jacocks and Cox 1992), inhibition of MAO (Miller et a…”
Background
Kava decreases the stereotyped behavior induced by amphetamine in mice
Krum, B. N., de Freitas, C. M., Ceretta, A. P. C., Barbosa, C. P., Reis, E. D. M., Scussel, R., Córneo, E. D. S., Machado‐de‐Ávila, R. A., Boligon, A. A., & Fachinetto, R. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113293 · Cited by 13
Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain
Bhattacharjee, A. K., Chang, L., Chen, M., White, L., Bell, J. M., Bazinet, R. P., & Rapoport, S. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008833 · Cited by 10
“, 1980), by stimulating DA synthesis (Uretsky and Snodgrass, 1977), and by inhibiting brain monoamine oxidase activity (Miller et al., 1980).”
Background
Amphetamines and Derivatives
Albertson, T. E., Kenyon, N. J., & Morrissey, B. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-0693-4.50049-9 · Cited by 10
The effects of a single dose of amphetamine and iprindole on the serotonergic system of the rat brain
Warren, P. F. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90115-1 · Cited by 10
Inhibition of monoamine oxidase by two substrate-analogues, with different preferences for 5-hydroxytryptamine neurons
Kim, S. K., Toyoshima, Y., Arai, Y., Kinemuchi, H., Tadano, T., Oyama, K., Satoh, N., & Kisara, K. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90057-i · Cited by 9
4-Phenyltetrahydroisoquinoline, but not nomifensine or cocaine, inhibits methamphetamine-induced dopamine release
Tateyama, M., Nagao, T., Ohta, S., Hirobe, M., & Hideki, O. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90544-r · Cited by 9
Simultaneous radioenzymatic assay of dopamine and dihydroxyphenylacetic acid: An index of in vivo dopamine release
Chengand, C. H., & Wooten, G. F. (1981) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(81)90008-5 · Cited by 9
Selective inhibition of MAO-A in serotonergic synaptosomes by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine
Arai, Y., KyungKim, S., Kinemuchi, H., Tadano, T., Satoh, S., Satoh, N., Oyama, K., & Kisara, K. (1990) · Neurochemistry International · doi:10.1016/0197-0186(90)90046-v · Cited by 9
Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review
Kämmerer, W. (2024) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2910 · Cited by 9
“In addition, dexamphetamine inhibits monoamine oxidase, resulting in a reduced breakdown of cytosolic monoamines (Miller et al., 1980).”
Attention-Deficit Hyperactivity Disorder (ADHD): A Comprehensive Overview of the Mechanistic Insights from Human Studies to Animal Models
Yacoub, M., Smith, S., Abbas, B., Iqbal, F., Jazieh, C., Shaer, N. S. H. A., Luk, C., & Syed, N. I. (2025) · Cells · doi:10.3390/cells14171367 · Cited by 18
“Concurrently, AMPH also impairs monoamine oxidase (MAO), preventing the breakdown of monoamines [213,214].”
On the role of monoamine oxidase-A for the maintenance of the volitional consumption of ethanol in two different rat models
Mega, B. T., Sheppard, K. W., Williams, H., & McMillen, B. A. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0616-0 · Cited by 8
Synthesis of α- and β-methyl derivatives of 2-[(5-methoxy-1-methyl)indol-2-yl]ethylamine as selective inhibitors of monoamine oxidases A and B.
García, C. F., Marco, J. L., & Alvarez, E. F. (1992) · Tetrahedron · doi:10.1016/s0040-4020(01)89882-3 · Cited by 8
Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats
Steranka, L. R. (1984) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00495943 · Cited by 8
“The inhibition of type A monoamine oxidase by amphetamine (Miller et al. 1980) is viewed as an important contributing factor since DA released intraneuronally after amphetamine administration would then be protected from enzymatic destruction, which would be expected to increase the extent of DA auto-oxidation.”
Background
Computational modeling of extracellular dopamine kinetics suggests low probability of neurotransmitter release
Rooney, K. E., & Wallace, L. J. (2015) · Synapse · doi:10.1002/syn.21845 · Cited by 8
Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies
Solomon, M. B., Yegla, B., Newcorn, J. H., Maletic, V., Rubin, J. S., & Robbins, T. W. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01473-4 · Cited by 9
“In addition, amphetamine inhibits monoamine oxidase [237, 238].”

Authors: Miller, H. H., Shore, P. A., & Clarke, D. E.
Affiliations: University of Houston (US)
University of Texas Health Science Center at Dallas (US)
Corresponding author: Clarke, David E.
ORCID: Clarke, David E.
Venue: Biochemical Pharmacology
Publisher: Elsevier BV
Published: 1980-05
Volume: 29
Issue: 10
Pages: 1347-1354
ISSN: 0006-2952 (ISSN-L)
DOI: 10.1016/0006-2952(80)90429-3
OpenAlex: W2032273250
Cited by: 120
References: 32
Citations by year: 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 2
FWCI: 2.44
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochemical Pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: d-amphetamine, L-amphetamine, monoamine oxidase inhibition, monoamine oxidase A, monoamine oxidase B, phenelzine, dopamine depletion, reserpine, cocaine, striatum
MeSH terms: Amphetamine, Animals, Brain, Cocaine, Corpus Striatum, Dextroamphetamine, Haloperidol, Male, Monoamine Oxidase Inhibitors, Phenelzine, 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-, 3,4-Dihydroxyphenylacetic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

In vivo monoamine oxidase inhibition by d-amphetamine

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks